Showing 2,661 - 2,680 results of 113,842 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( 50 ((a decrease) OR (mean decrease)) ))', query time: 1.67s Refine Results
  1. 2661
  2. 2662
  3. 2663
  4. 2664
  5. 2665
  6. 2666
  7. 2667
  8. 2668

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

    Published 2025
    “…(B) For each group, the median Ki-67 immunostained parathyroid sample closest to the group mean is shown. Each dot represents one sample. Scale bars measures 50μm.…”
  9. 2669
  10. 2670

    To be funny or not to be funny: Gender differences in student perceptions of instructor humor in college science courses by Katelyn M. Cooper (5634851)

    Published 2018
    “…<div><p>For over 50 years instructor humor has been recognized as a way to positively impact student cognitive and affective learning. …”
  11. 2671

    Androgen and staurosporine synergize to decrease the relative ATP concentration in HPr-1AR cells. by Congcong Chen (796149)

    Published 2016
    “…In comparison to vehicle control, STS and to a lesser extent DHT significantly decrease the relative ATP concentration of HPr-1AR cells at 24 hours. …”
  12. 2672
  13. 2673
  14. 2674
  15. 2675
  16. 2676
  17. 2677
  18. 2678

    Prey establishment and decrease in inter-population contacts protects T6SS sensitive lineages. by Marta Rudzite (15991136)

    Published 2023
    “…Representative simulation outputs showing how decrease in initial bacterial density (<b>C</b>) or changes in strain mixing ratio (<b>E</b>) within initial population promotes prey (red) survival in a mix attacker population (green) with differing mean of T6SS firing rate and within a context of highly lytic toxins. …”
  19. 2679
  20. 2680

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…<i>N</i>-(4-Bromophenyl)-4-(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-6-morpholino-1,3,5-triazin-2-amine <b>4f</b>, <i>N</i>-(4-chlorophenyl)-4,6-bis­(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-1,3,5-triazin-2-amine <b>5c</b>, and 4,6-<i>bis</i>(3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)-<i>N</i>-(4-methoxyphenyl)-1,3,5-triazin-2-amine <b>5d</b> showed promising activity against these cancer cells: <b>4f</b> [(IC<sub>50</sub> = 4.53 ± 0.30 μM (MCF-7); 0.50 ± 0.080 μM (HCT-116); and 3.01 ± 0.49 μM (HepG2)]; <b>5d</b> [(IC<sub>50</sub> = 3.66 ± 0.96 μM (HCT-116); and 5.42 ± 0.82 μM (HepG2)]; and <b>5c</b> [(IC<sub>50</sub> = 2.29 ± 0.92 μM (MCF-7)]. …”